rescinnamine

Ligand id: 7098

Name: rescinnamine

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 11
Topological polar surface area 117.78
Molecular weight 634.29
XLogP 3.39
No. Lipinski's rules broken 1

Molecular properties generated using the CDK

Classification
Compound class Natural product or derivative
Approved drug? Yes
IUPAC Name
methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
International Nonproprietary Names
INN number INN
683 rescinnamine
Database Links
CAS Registry No. 24815-24-5
ChEBI CHEBI:28572
ChEMBL Ligand CHEMBL1668
DrugBank Ligand DB01180
PubChem CID 5280954
Search Google for chemical match using the InChIKey SZLZWPPUNLXJEA-QEGASFHISA-N
Search Google for chemicals with the same backbone SZLZWPPUNLXJEA
Search PubMed clinical trials rescinnamine
Search PubMed titles rescinnamine
Search PubMed titles/abstracts rescinnamine
Wikipedia Rescinnamine
Comments
Rescinnamine is an angiotensin-converting enzyme (ACE) inhibitor. There is no information regarding approval for clinical use of this drug on the US FDA website. Other national approval agencies may have granted marketing authorisation.